A Post-marketing Clinical Study of a Third Dose of the Inactivated SARS-CoV-2 Vaccine (Vero Cells) (Produced in Beijing): Immunogenicity, Safety and Antibody Persistence Assessments in Patients With Hypertension and/or Diabetes
Latest Information Update: 05 Oct 2023
At a glance
- Drugs Coronavirus vaccine-Wuhan Institute of Biological Products (Primary)
- Indications COVID 2019 infections
- Focus Pharmacokinetics
- Sponsors China National Biotec Group
- 09 Nov 2021 New trial record